The U.S. Court of Appeals for the Federal Circuit recently ended much of the controversy surrounding product-by-process claims in Abbott Laboratories v. Sandoz, Inc., but arguably created a new debate…
Category: Infringement
Interpreting 35 U.S.C. §271(f): Method claims not covered
In a recent decision, the U.S. Court of Appeals for the Federal Circuit (CAFC) ruled that method claims in patents cannot be infringed under 35 U.S.C. §271(f). This section of…
Patent Cures, Not Genes, Cancer Patients Argue: Easier Said Than Done
Australia is now at the centre of the global gene patent debate with a Senate inquiry that began last week in Melbourne. Senators in Australia began hearing public submissions on…
Patent Prosecution as Part of Business Models?
On Monday, July 13th, Mosaid Technologies Inc. filed a suit against IBM Corporation for patent infringement concerning six of Mosaid’s United States patents. The suit was filed in the United…
iPhones soon to find their way in China
Massive uncertainty looms around the future of Apple’s iPhone as Apple hits a new pothole in its rough journey to release iPhones in the Chinese subscriber market. The reason behind…
United States Doctrine of Inequitable Conduct Under Scrutiny Again
The controversial doctrine of inequitable conduct has once again garnered much attention in the patent law community due to the recent denial of certiorari by the US Supreme Court in Aventis Pharma v.…